CRO Analytics, ACRP Partner To Assess Clinical Trial Quality
CRO Analytics, a provider of validated clinical trial performance data, announced a partnership with the Association of Clinical Research Professionals focused on measuring investigator site personnel views of clinical trial quality
CRO Analytics, a provider of validated clinical trial performance data, announced a partnership with the Association of Clinical Research Professionals (ACRP) focused on measuring investigator site personnel views of clinical trial quality. The collaboration will provide critical insight into the quality of clinical trials, key drivers of that quality, and methods to improve clinical research.
CRO Analytics will develop a statistically validated data collection instrument to be used with the Performer™ platform, and work with ACRP to collect assessments from investigator site personnel. That data will be analyzed using the cloud-based SaaS software application through a series of algorithms and generate benchmarking, key driver analytics, and predictive analytics.
Final ENLIVEN Trial Results Confirm Long-Term Benefit of Turalio in Tenosynovial Giant Cell Tumor
July 9th 2025In final data from the Phase III ENLIVEN study, Turalio (pexidartinib) demonstrated durable tumor responses and a consistent safety profile in patients with symptomatic TGCT not amenable to surgery.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Expands Farapulse PFA Approval to Persistent AF After Strong ADVANTAGE AF Trial Results
July 7th 2025Boston Scientific’s Farapulse Pulsed Field Ablation System is now approved for treating persistent atrial fibrillation, following 12-month data from the ADVANTAGE AF trial showing strong safety, high freedom from AF, and no major complications.
Effect of AI/ML, Real World Evidence and Master Protocols on Trial Success
July 7th 2025How the application of artificial intelligence, broader use of real-world evidence, decentralized clinical trials, master protocols, and risk-based quality monitoring, together with strong ethical oversight and increased collaboration, are contributing to better healthcare delivery and strengthening the role of clinical research in driving global health progress.
